Produkty 19037-28-6

CAS 19037-28-6 występuje w naszej ofercie pod nazwami: 3-epi-Pregnenolone, >95% (HPLC), 3-epi-Pregnenolone. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 2,5mg, 25mg, 50mg, 2000mg, 5000mg.

3-epi-Pregnenolone, >95% (HPLC)
TRC
  • opakowanie: 2,5mg, 25mg
  • Warianty: 2
Zobacz produkt
3-epi-Pregnenolone
Biosynth
  • opakowanie: 50mg, 2000mg, 5000mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1-[(3R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone (CAS 19037-28-6) to związek chemiczny o wzorze sumarycznym C21H32O2 i masie molowej 316.5 g/mol. Nazwa systematyczna IUPAC: 1-[(3R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone. InChIKey: ORNBQBCIOKFOEO-QYYVTAPASA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H32O2
Masa molowa316.5 g/mol
Nazwa IUPAC1-[(3R,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
InChIKeyORNBQBCIOKFOEO-QYYVTAPASA-N
SMILESCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@H](C4)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 3alpha-Hydroxypregn-5-en-20-one, Pregn-5-en-20-one, 3alpha-hydroxy-, 3-epi-Pregnenolone, 5-pregnene-3alpha-ol-20-one, Pregn-5-en-20-one, 3-hydroxy-, (3a)-, 3alpha-hydroxy-pregn-5-en-20-one, (3alpha)-3-hydroxypregn-5-en-20-one
Powiązane formy tego związku
1-[(3S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H32O2
1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H32O2
2,2,2-trideuterio-1-[(3S,8S,9S,10R,13S,14S,17S)-17-deuterio-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone C21H32O2
Izomery (ten sam wzór sumaryczny)
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol C21H32O2
ethyl (4Z,7Z,10Z,13Z,16Z)-nonadeca-4,7,10,13,16-pentaenoate C21H32O2
(8S,9S,10R,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H32O2
(8S,9S,10R,13S,14S,17S)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H32O2
1-[(3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C21H32O2
(3S,5R,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C21H32O2
(3R,5R,8R,9R,10S,13S,14S,17R)-13-ethyl-17-ethynyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C21H32O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-4,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H32O2
ethyl (5Z,8Z,11Z,14Z,17Z)-nonadeca-5,8,11,14,17-pentaenoate C21H32O2